Parkinson's disease with homozygous PINK1 p.Leu489Pro mutations in two Indian sisters

被引:0
|
作者
Lim, Shen-Yang [1 ,2 ]
Ahmad-Annuar, Azlina [3 ]
Lohmann, Katja [4 ]
Tan, Ai Huey [1 ,2 ]
Tay, Yi Wen [3 ]
Lim, Jia Lun [2 ,3 ]
Ramli, Norlisah [5 ]
Teh, Pei Chiek [6 ]
Kuppusamy, Rishikesan [7 ]
Tan, Chong Tin [1 ]
Goh, Khean Jin [1 ]
Viswanathan, Shanthi [8 ]
Bauer, Peter [9 ]
Rolfs, Arndt [9 ]
Klein, Christine [4 ]
机构
[1] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia
[3] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia
[4] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[5] Univ Malaya, Fac Med, Div Neuroradiol, Kuala Lumpur, Malaysia
[6] Hosp Tuanku Jaafar Seremban, Seremban, Malaysia
[7] Pantai Hosp Bangsar, Kuala Lumpur, Malaysia
[8] Hosp Kuala Lumpur, Div Neurol, Kuala Lumpur, Malaysia
[9] Centogene AG, Rostock, Germany
关键词
Parkinson's disease; PINK1; genetics; Asian; Indian; clozapine; MRI; corticospinal tract;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe the clinical features of two sisters with Parkinson?s disease (PD) of Indian descent living in Malaysia. Both were homozygous for the known PINK1 mutation p.Leu489Pro (c.1466T>C). The proband, who has been followed up by us over a span of 35 years, had a fairly ?classic? clinical presentation for PARK-PINK1, including young onset, a clear response to dopamine replacement therapy, and development of troublesome motor fluctuations and dyskinesias. Her dyskinesias improved substantially with clozapine treatment, which to our knowledge has not specifically been reported for PARK-PINK1; this treatment has been sustained for nearly a decade. The clinical phenotype of the older sister was more akin to later-onset ?idiopathic? PD; however, her brain MRI showed abnormal signal in the posterior limb of the internal capsules and the hypothalamus. Our report contributes to the scarce literature on monogenic PD in the Malaysian / Indian population, and further supports the pathogenicity of the PINK1 p.Leu489Pro variant.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 50 条
  • [1] Pink1 heterozygous mutations in familial Parkinson's disease
    Hayashida, A.
    Li, Y.
    Yoshino, H.
    Nakahara, T.
    Yoritaka, A.
    Nagara, Y.
    Sakiyama, Y.
    Kusaka, H.
    Takiyama, Y.
    Morimoto, N.
    Uchino, A.
    Fujimoto, T.
    Sekijima, Y.
    Tomimoto, H.
    Tsuruta, K.
    Hattori, Y.
    Kashihara, K.
    Funayama, M.
    Nishioka, K.
    Hattori, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 161 - +
  • [2] A heterozygous effect for PINK1 mutations in Parkinson's disease?
    Abou-Sleiman, Patrick M.
    Muqit, Miratul M. K.
    McDonald, Neil Q.
    Yang, Yan Xiang
    Gandhi, Sonia
    Healy, Daniel G.
    Harvey, Kirsten
    Harvey, Robert J.
    Deas, Emma
    Hatia, Kailash
    Quinn, Niall
    Lees, Andrew
    Latchman, David S.
    Wood, Nicholas W.
    ANNALS OF NEUROLOGY, 2006, 60 (04) : 414 - 419
  • [3] PINK1 p.Leu347Pro mutations in Malays: Prevalence and illustrative cases
    Tan, Ai Huey
    Lohmann, Katja
    Tay, Yi Wen
    Lim, Jia Lun
    Ahmad-Annuar, Azlina
    Ramli, Norlisah
    Chin, Yen Theng
    Mawardi, Ahmad Shahir
    Azmi, Khairul
    Aziz, Zariah Abdul
    Puvanarajah, Santhi Datuk
    Bauer, Peter
    Klein, Christine
    Rolfs, Arndt
    Lim, Shen-Yang
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : 34 - 39
  • [4] Parkinson's disease - Pro-survival effects of PINK1
    Abeliovich, Asa
    NATURE, 2007, 448 (7155) : 759 - 760
  • [5] Evaluation of PINK1 variants in Indian Parkinson's disease patients
    Biswas, Arindam
    Sadhukhan, Tamal
    Majumder, Sayantani
    Misra, Amar K.
    Das, Shyamal K.
    Ray, Kunal
    Ray, Jharna
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (03) : 167 - 171
  • [6] Bioenergetic Consequences of PINK1 Mutations in Parkinson Disease
    Abramov, Andrey Yurevich
    Gegg, Matthew
    Grunewald, Anne
    Wood, Nicholas William
    Klein, Christine
    Schapira, Anthony Henry Vernon
    PLOS ONE, 2011, 6 (10):
  • [7] Clinicogenetic study of PINK1 mutations in Parkinson disease
    Li, Y.
    Kumazawa, R.
    Tomiyama, H.
    Imamichi, Y.
    Funayama, M.
    Yoshino, H.
    Sato, K.
    Takahashi, H.
    Yoshii, F.
    Hattori, N.
    Mizuno, Y.
    MOVEMENT DISORDERS, 2006, 21 : S414 - S414
  • [8] Structure of PINK1 and mechanisms of Parkinson's disease-associated mutations
    Kumar, Atul
    Tamjar, Jevgenia
    Waddell, Andrew D.
    Woodroof, Helen I.
    Raimi, Olawale G.
    Shaw, Andrew M.
    Peggie, Mark
    Muqit, Miratul M. K.
    van Aalten, Daan M. F.
    ELIFE, 2017, 6
  • [9] PINK1 mutations in sporadic early-onset Parkinson's disease
    Tan, Eng-King
    Yew, Kenneth
    Chua, Eva
    Puvan, K.
    Shen, Hui
    Lee, Esther
    Puong, Kim-Yoong
    Zhao, Yi
    Pavanni, Ratnagopal
    Wong, Meng-Cheong
    Jamora, Dominic
    de Silva, Deidre
    Moe, Kyaw-Thu
    Woon, Fung-Peng
    Yuen, Yih
    Tan, Louis
    MOVEMENT DISORDERS, 2006, 21 (06) : 789 - 793
  • [10] Heterozygous PINK1 mutations:: A susceptibility factor for Parkinson disease?
    Djarmati, Ana
    Hedrich, Katja
    Svetel, Marina
    Lohnau, Thora
    Schwinger, Eberhard
    Romac, Stanka
    Pramstaller, Peter P.
    Kostic, Vladimir
    Klein, Christine
    MOVEMENT DISORDERS, 2006, 21 (09) : 1526 - 1530